Drawing for META HEALTH

USPTO serial 97224726

META HEALTH

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
—
Law office
NEW APPLICATION PROCESSING

What this means

Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies. Wait for assignment and the first examiner action. Monitor TSDR monthly for status changes to 638 (assigned) or an office action.

Status 630: Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies.

Need help with META HEALTH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
042Biotechnology research; Drug discovery services; Consulting services in the field of biotechnology; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Pharmaceutical drug development services; Research and development in the pharmaceutical and biotechnology fields; Scientific study and research in the field(s) of health care deliveryACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 18, 2022CRAFAMENDMENT CORRESPONDENCE ENTERED—
Jan 24, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 21, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance